In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers
Antiviral Therapy2011Vol. 16(8), pp. 1259–1266
Citations Over TimeTop 10% of 2011 papers
M Viganò, Stefano Mora, Vania Giacomet, Sara Stucchi, Valeria Manfredini, Clara Gabiano, Filippo Salvini, Monica Cellini, Enrica Tamburrini, Maria Puzzovio, Gianvincenzo Zuccotti
Abstract
Exposure to TDF during pregnancy does not impair growth patterns, bone health and markers of bone metabolism in SR infants and young children born to HIV-infected women.
Related Papers
- → Mitomycin C potentiates ultraviolet-related cytotoxicity in corneal fibroblasts.(2008)34 cited
- Nevirapine resistance after single dose prophylaxis.(2003)
- → Pharmacological implications of lengthened in-utero exposure to nevirapine(2000)28 cited
- → Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission(2010)5 cited
- Affordable, effective drug regimen for infants of mothers with HIV.(1999)